Arthroscopic Knee Surgery Clinical Trial
— Salty KneeOfficial title:
Safety and Efficacy of Hyperosmolar Saline Irrigation Fluid in Arthroscopic Knee Surgery
Verified date | August 2020 |
Source | University of Missouri-Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
An isotonic solution, such as saline (0.9%, 300mOsm/L) or lactated ringer's (273 mOsm/L), is commonly used and safely proven for joint irrigation during arthroscopy. Arthroscopic fluid is usually pressurized to enable visualization through dilation of the joint or bursa and prevent bleeding from the microvasculature. It has been recommended that this pressure be maintained at 49mmHg or less below the systolic blood pressure to preserve the clarity of view. The combination of large amounts of pressurized irrigation solution and lengthy arthroscopic procedures may cause substantial tissue fluid retention. Thus, extravasation of irrigation fluid into the periarticular tissues is inevitable and may create technical difficulties as well as patient morbidity and complications. Previous investigators have reported complications including tracheal obstruction, post-operative airway edema and compromise leading to prolonged intubation, excess weight gain, neurologic injuries, skin necrosis, and fluid overload associated with excessive fluid extravasation and tissue retention. Furthermore, it has been shown that fluid accumulated during the operation is slowly released back into the systemic circulation. Although there is not a rapid change in circulating volume, there may be implications for elderly patients and those with multiple comorbidities during prolonged arthroscopic surgery. Therefore the investigators seek to determine if a hyperosmolar solution, similar to what is used in head trauma patients, can reduce the degree of fluid extravasation in knee arthroscopy. The investigators also seek to determine if a hyperosmolar solution has any effect on post-operative knee pain compared to the standard isotonic solution. The third objective is to determine if a hyperosmolar solution has any effect on post-operative pain medicine consumption compared to the standard isotonic solution.
Status | Completed |
Enrollment | 48 |
Est. completion date | September 5, 2019 |
Est. primary completion date | September 5, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adult patients (18 years of age or greater) undergoing arthroscopic knee surgery who are willing and able to consent. Exclusion Criteria: - Current pregnancy or breastfeeding - Unable to give consent - Prisoner - Mentally Disabled |
Country | Name | City | State |
---|---|---|---|
United States | University of Missouri Health System | Columbia | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Missouri-Columbia |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fluid Extravasation | To determine if a hyperosmolar solution, similar to what is used in head trauma patients, can change the degree of fluid extravasation in knee arthroscopy. | Immediately Postoperatively | |
Secondary | Postoperative Pain | To determine if a hyperosmolar solution has any effect on post-operative knee pain (Visual Analogue Scale; 0-10; 0= no pain; 10= worst pain imaginable) compared to the standard isotonic solution. | Post-operative Days 1, 2 and 3 | |
Secondary | Opioid Consumption | To determine if a hyperosmolar solution has any effect on post-operative pain medicine consumption compared to the standard isotonic solution. | Postoperative Days 1, 2 and 3. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01650519 -
A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery
|
Phase 4 | |
Completed |
NCT02001662 -
Adductor Canal Block and Arthroscopic Knee Surgery, High Pain Responders
|
Phase 4 | |
Completed |
NCT04759742 -
The Optimal Dosage of Ropivacaine for Arthroscopic Knee Surgery
|
Early Phase 1 | |
Recruiting |
NCT06382896 -
Effect of Oliceridine on Rebound Pain
|
||
Completed |
NCT02089932 -
Dexmedetomidine in Different Dose Levels as Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block.
|
Phase 4 | |
Completed |
NCT01701102 -
Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery
|
N/A | |
Completed |
NCT04322760 -
Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery
|
N/A | |
Not yet recruiting |
NCT02742376 -
Comparison of Gait Parameters Between Floor and Sponge Surfaces and Special Shoes
|
N/A |